semaglutide studies SELECT Trial Comparative efficacy, safety, and cardiovascular
Description
Get Started With Noom 3
Overall, lacks transparency and clinical studies to back up this blend
J., Wells, S
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Anam M, Maharjan S, Amjad Z, Abaza A, Vasavada AM, Sadhu A, et al
They were taken away in an esky for forensic testing
In the STEP-4 trial, 902 participants received semaglutide 2.4 mg for the initial 20 weeks, and were then randomly assigned to receive either (a) semaglutide or (b) a placebo for the remaining 48 weeks (4)
